 Claudia Mickael
Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 23 | 2025 | 1910 | 3.020 |
Why?
| | Hypoxia | 12 | 2025 | 1112 | 1.870 |
Why?
| | Schistosoma | 5 | 2024 | 28 | 1.650 |
Why?
| | Schistosomiasis | 8 | 2024 | 47 | 1.620 |
Why?
| | Poultry Diseases | 7 | 2011 | 12 | 0.970 |
Why?
| | Platelet Activation | 1 | 2024 | 93 | 0.860 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5757 | 0.780 |
Why?
| | Th2 Cells | 4 | 2024 | 176 | 0.780 |
Why?
| | Salmonella enteritidis | 6 | 2011 | 19 | 0.760 |
Why?
| | Macrophages | 8 | 2025 | 1547 | 0.740 |
Why?
| | Dendritic Cells | 1 | 2024 | 483 | 0.700 |
Why?
| | Blood Platelets | 1 | 2024 | 408 | 0.690 |
Why?
| | Salmonella Infections, Animal | 5 | 2011 | 38 | 0.660 |
Why?
| | Receptors, Interleukin-6 | 1 | 2019 | 43 | 0.620 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2025 | 261 | 0.590 |
Why?
| | Schistosoma mansoni | 6 | 2024 | 37 | 0.580 |
Why?
| | Thrombospondin 1 | 5 | 2025 | 27 | 0.570 |
Why?
| | Heart Ventricles | 5 | 2021 | 788 | 0.540 |
Why?
| | Disease Susceptibility | 1 | 2019 | 347 | 0.520 |
Why?
| | Chickens | 7 | 2011 | 191 | 0.510 |
Why?
| | Familial Primary Pulmonary Hypertension | 3 | 2022 | 198 | 0.510 |
Why?
| | Lung | 11 | 2025 | 4060 | 0.500 |
Why?
| | Virulence Factors | 4 | 2010 | 167 | 0.460 |
Why?
| | Transforming Growth Factor beta | 5 | 2020 | 480 | 0.430 |
Why?
| | Animals | 31 | 2025 | 36940 | 0.420 |
Why?
| | Pulmonary Artery | 4 | 2025 | 1086 | 0.410 |
Why?
| | Schistosomiasis mansoni | 4 | 2024 | 23 | 0.410 |
Why?
| | Bacterial Proteins | 5 | 2011 | 879 | 0.390 |
Why?
| | Superoxide Dismutase | 2 | 2025 | 346 | 0.390 |
Why?
| | Mice | 16 | 2025 | 17787 | 0.370 |
Why?
| | Metabolome | 2 | 2025 | 350 | 0.310 |
Why?
| | Infectious bursal disease virus | 2 | 2006 | 2 | 0.300 |
Why?
| | Epithelial Cells | 3 | 2010 | 1096 | 0.280 |
Why?
| | Monocytes | 3 | 2025 | 563 | 0.260 |
Why?
| | Genomic Islands | 3 | 2010 | 9 | 0.250 |
Why?
| | Heart Failure | 1 | 2019 | 2236 | 0.240 |
Why?
| | Viral Structural Proteins | 1 | 2005 | 13 | 0.240 |
Why?
| | Vascular Remodeling | 4 | 2022 | 193 | 0.240 |
Why?
| | Dexamethasone | 2 | 2025 | 368 | 0.230 |
Why?
| | Complement C5a | 1 | 2024 | 71 | 0.220 |
Why?
| | Complement C3a | 1 | 2024 | 42 | 0.220 |
Why?
| | Connective Tissue Diseases | 1 | 2025 | 84 | 0.220 |
Why?
| | Gene Deletion | 2 | 2019 | 391 | 0.210 |
Why?
| | Hyaluronic Acid | 1 | 2025 | 225 | 0.200 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 976 | 0.200 |
Why?
| | Epitopes | 1 | 2005 | 479 | 0.200 |
Why?
| | Italy | 1 | 2022 | 110 | 0.190 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 2 | 2021 | 51 | 0.190 |
Why?
| | Schistosoma japonicum | 1 | 2022 | 31 | 0.190 |
Why?
| | Phosphofructokinase-2 | 1 | 2021 | 15 | 0.180 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 21 | 0.180 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2025 | 446 | 0.180 |
Why?
| | Scleroderma, Systemic | 1 | 2022 | 122 | 0.180 |
Why?
| | Complement System Proteins | 1 | 2024 | 327 | 0.180 |
Why?
| | Complement Activation | 1 | 2024 | 415 | 0.180 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 313 | 0.180 |
Why?
| | Inflammation | 5 | 2025 | 2837 | 0.170 |
Why?
| | Transcriptome | 2 | 2024 | 971 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 558 | 0.170 |
Why?
| | Bacterial Vaccines | 2 | 2011 | 63 | 0.170 |
Why?
| | Interleukin-4 | 2 | 2024 | 216 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 278 | 0.160 |
Why?
| | Isotope Labeling | 1 | 2020 | 81 | 0.160 |
Why?
| | Coronary Vessels | 1 | 2021 | 248 | 0.160 |
Why?
| | Pulmonary Fibrosis | 1 | 2023 | 402 | 0.150 |
Why?
| | Vasoconstriction | 1 | 2020 | 202 | 0.150 |
Why?
| | SOXF Transcription Factors | 1 | 2018 | 16 | 0.150 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.150 |
Why?
| | Humans | 20 | 2025 | 137585 | 0.150 |
Why?
| | Rats, Inbred F344 | 1 | 2019 | 265 | 0.150 |
Why?
| | HLA-DP beta-Chains | 1 | 2018 | 86 | 0.150 |
Why?
| | Mice, Knockout | 5 | 2025 | 3015 | 0.140 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4295 | 0.140 |
Why?
| | Female | 14 | 2025 | 73304 | 0.140 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2024 | 1091 | 0.140 |
Why?
| | Fatty Acids | 2 | 2022 | 443 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1774 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2189 | 0.130 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 266 | 0.130 |
Why?
| | Birnaviridae Infections | 2 | 2006 | 2 | 0.120 |
Why?
| | Rats | 3 | 2022 | 5647 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 332 | 0.120 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 316 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2019 | 449 | 0.120 |
Why?
| | Male | 8 | 2025 | 67762 | 0.120 |
Why?
| | Proteomics | 1 | 2022 | 1111 | 0.120 |
Why?
| | Disease Progression | 1 | 2022 | 2757 | 0.110 |
Why?
| | Interleukin-13 | 1 | 2015 | 149 | 0.110 |
Why?
| | Receptors, CCR2 | 2 | 2025 | 40 | 0.110 |
Why?
| | Adaptation, Physiological | 1 | 2018 | 553 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.110 |
Why?
| | Pneumonia | 1 | 2019 | 639 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 927 | 0.100 |
Why?
| | Caco-2 Cells | 2 | 2010 | 77 | 0.100 |
Why?
| | Antibodies, Bacterial | 2 | 2011 | 146 | 0.100 |
Why?
| | Virulence | 2 | 2010 | 267 | 0.100 |
Why?
| | Signal Transduction | 6 | 2021 | 5079 | 0.090 |
Why?
| | Macrophages, Alveolar | 2 | 2024 | 391 | 0.090 |
Why?
| | Extracellular Matrix | 2 | 2025 | 528 | 0.080 |
Why?
| | Ferrichrome | 1 | 2010 | 1 | 0.080 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2010 | 26 | 0.080 |
Why?
| | Genetic Complementation Test | 1 | 2010 | 67 | 0.080 |
Why?
| | Edetic Acid | 1 | 2010 | 50 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 1020 | 0.080 |
Why?
| | Salmonella Infections | 1 | 2010 | 57 | 0.080 |
Why?
| | Locomotion | 1 | 2010 | 106 | 0.080 |
Why?
| | Membrane Transport Proteins | 1 | 2010 | 162 | 0.080 |
Why?
| | Immunization | 1 | 2011 | 411 | 0.080 |
Why?
| | Biomarkers | 1 | 2019 | 4149 | 0.070 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 243 | 0.070 |
Why?
| | Intestines | 1 | 2010 | 357 | 0.070 |
Why?
| | Campylobacter jejuni | 1 | 2006 | 12 | 0.060 |
Why?
| | Campylobacter Infections | 1 | 2006 | 17 | 0.060 |
Why?
| | Virus Shedding | 1 | 2006 | 48 | 0.060 |
Why?
| | Pyrroles | 2 | 2018 | 213 | 0.060 |
Why?
| | Bursa of Fabricius | 1 | 2005 | 2 | 0.060 |
Why?
| | Epitope Mapping | 1 | 2005 | 62 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2011 | 1164 | 0.060 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 115 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2021 | 785 | 0.060 |
Why?
| | Fingolimod Hydrochloride | 1 | 2024 | 40 | 0.050 |
Why?
| | Drug Design | 1 | 2005 | 167 | 0.050 |
Why?
| | Viral Vaccines | 1 | 2005 | 98 | 0.050 |
Why?
| | Indoles | 2 | 2018 | 412 | 0.050 |
Why?
| | Cellular Reprogramming | 1 | 2024 | 99 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2005 | 812 | 0.050 |
Why?
| | Cardiac Catheterization | 1 | 2025 | 530 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2020 | 2475 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2021 | 64 | 0.050 |
Why?
| | Base Sequence | 1 | 2005 | 2181 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2486 | 0.040 |
Why?
| | RNA, Viral | 1 | 2005 | 656 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2139 | 0.040 |
Why?
| | Parabiosis | 1 | 2020 | 11 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 499 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2900 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 552 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 179 | 0.040 |
Why?
| | Cecum | 2 | 2010 | 33 | 0.040 |
Why?
| | rho-Associated Kinases | 1 | 2020 | 83 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2020 | 57 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2020 | 53 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1809 | 0.040 |
Why?
| | Vascular Resistance | 1 | 2021 | 375 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 165 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 678 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 452 | 0.040 |
Why?
| | Altitude | 1 | 2023 | 488 | 0.040 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2018 | 59 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1317 | 0.040 |
Why?
| | Glycolysis | 1 | 2020 | 321 | 0.040 |
Why?
| | Spleen | 2 | 2010 | 514 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2017 | 44 | 0.030 |
Why?
| | Cytokines | 1 | 2024 | 2085 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1113 | 0.030 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 8 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1996 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 2015 | 27 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2015 | 43 | 0.030 |
Why?
| | Smad2 Protein | 1 | 2015 | 38 | 0.030 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2015 | 19 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3196 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2015 | 59 | 0.030 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 108 | 0.030 |
Why?
| | Th1 Cells | 1 | 2015 | 143 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 178 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 984 | 0.030 |
Why?
| | Th17 Cells | 1 | 2015 | 108 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 181 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 286 | 0.030 |
Why?
| | Biological Transport | 1 | 2015 | 418 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2015 | 382 | 0.030 |
Why?
| | Mutation | 1 | 2005 | 3958 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 294 | 0.030 |
Why?
| | Genetic Variation | 1 | 2018 | 991 | 0.030 |
Why?
| | Exercise | 1 | 2025 | 2057 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1786 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2020 | 4193 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3556 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1431 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1060 | 0.020 |
Why?
| | Bacterial Load | 1 | 2011 | 68 | 0.020 |
Why?
| | Liver | 2 | 2010 | 1943 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1759 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 33479 | 0.020 |
Why?
| | Bacterial Secretion Systems | 1 | 2010 | 6 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 60 | 0.020 |
Why?
| | Adult | 2 | 2025 | 37929 | 0.020 |
Why?
| | Apoptosis | 1 | 2018 | 2553 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2833 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 916 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2009 | 156 | 0.020 |
Why?
| | Rabbits | 1 | 2010 | 794 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2009 | 183 | 0.020 |
Why?
| | Intestine, Small | 1 | 2009 | 156 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2009 | 337 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 893 | 0.020 |
Why?
| | Gastrointestinal Contents | 1 | 2006 | 8 | 0.020 |
Why?
| | Aged | 1 | 2025 | 23961 | 0.010 |
Why?
| | Cell Line | 1 | 2010 | 2847 | 0.010 |
Why?
| | Immune Tolerance | 1 | 2006 | 363 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 623 | 0.010 |
Why?
| | Feces | 1 | 2006 | 484 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 21513 | 0.010 |
Why?
|
|
Mickael's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|